Press Resease

Nanoemulsion Market - Global Industry Analysis

Nanoemulsion Market by Drug Class (Anesthetics, Steroids, NSAIDs, Immunosuppressant, Antimicrobials, Antiretroviral, Vasodilators, and Others), by Route of Administration (Topical, Parenteral, Oral, and Nasal), and by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 17-May-2019 Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-4130 Status : Published

Global nanoemulsion market expected to generate around USD 15,290 million by 2025, at a CAGR of around 9.5 % between 2019 and 2025. Nanoemulsion is the novel drug delivery system or targeted drug delivery system that consists of water and emulsified oil with an average droplet diameter ranging from 50 to 1000 nm.

Description

The report covers a forecast and an analysis of the nanoemulsion market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the nanoemulsion market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the nanoemulsion market on a global level.

In order to give the users of this report a comprehensive view of the nanoemulsion market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Nanoemulsion Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the nanoemulsion market by segmenting it based on drug class, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Southeast Asia, Brazil, and Mexico.

Some major players operating in the global nanoemulsion market are Mitsubishi Tanabe Pharma, AbbVie, Allergan, Fresenius Kabi, AstraZeneca, GlaxoSmithKline, Kaken Pharmaceutical, Sanofi, Novartis, and B. Braun Melsungen.

This report segments the global nanoemulsion market into:

Global Nanoemulsion Market: Drug Class Analysis

  • Anesthetics
  • Steroids
  • NSAIDs
  • Immunosuppressant
  • Antimicrobials
  • Antiretroviral
  • Vasodilators
  • Others

Global Nanoemulsion Market: Route of Administration Analysis

  • Topical
  • Parenteral
  • Oral
  • Nasal

Global Nanoemulsion Market: Distribution Channel Analysis

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Global Nanoemulsion Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global nanoemulsion market, 2017-2025 (USD Million)
    • 2.2. Global nanoemulsion market: Snapshot
  •  
  • Chapter 3. Nanoemulsion Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global nanoemulsion market drivers: Impact analysis
      • 3.2.2. The emergence of cost-effective technologies for formulation development
      • 3.2.3. Increasing research and development activities
    • 3.3. Market Restraints
      • 3.3.1. Global nanoemulsion market restraints: Impact analysis
      • 3.3.2. Nanoemulsion stability is influenced by environmental parameters
    • 3.4. Opportunities
      • 3.4.1. Rising chronic diseases
      • 3.4.2. The increasing need for new technologies for formulation development
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by drug class
      • 3.6.2. Market attractiveness analysis, by route of administration
      • 3.6.3. Market attractiveness analysis, by distribution channel
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Nanoemulsion Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global nanoemulsion market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Nanoemulsion Market - Drug Class Analysis
    • 5.1. Global nanoemulsion market: drug class overview
      • 5.1.1. Global nanoemulsion market revenue share, by drug class, 2018 and 2025
    • 5.2. Anesthetics
      • 5.2.1. Global anesthetics market, 2017-2025 (USD Million)
    • 5.3. Steroids
      • 5.3.1. Global steroids market, 2017-2025 (USD Million)
    • 5.4. NSAIDs
      • 5.4.1. Global NSAIDs market, 2017-2025 (USD Million)
    • 5.5. Immunosuppressant
      • 5.5.1. Global immunosuppressant market, 2017-2025 (USD Million)
    • 5.6. Antimicrobials
      • 5.6.1. Global antimicrobials market, 2017-2025 (USD Million)
    • 5.7. Antiretroviral
      • 5.7.1. Global antiretroviral market, 2017-2025 (USD Million)
    • 5.8. Vasodilators
      • 5.8.1. Global vasodilators market, 2017-2025 (USD Million)
    • 5.9. Others
      • 5.9.1. Global others market, 2017-2025 (USD Million)
  •  
  • Chapter 6. Global Nanoemulsion Market - Route of Administration Analysis
    • 6.1. Global nanoemulsion market: Route of Administration overview
      • 6.1.1. Global nanoemulsion market revenue share, by route of administration, 2018 and 2025
    • 6.2. Topical
      • 6.2.1. Global nanoemulsion market for topical, 2017-2025 (USD Million)
    • 6.3. Parenteral
      • 6.3.1. Global nanoemulsion market for parenteral, 2017-2025 (USD Million)
    • 6.4. Oral
      • 6.4.1. Global nanoemulsion market for oral, 2017-2025 (USD Million)
    • 6.5. Nasal
      • 6.5.1. Global nanoemulsion market for nasal, 2017-2025 (USD Million)
  •  
  • Chapter 7. Global Nanoemulsion Market - Distribution Channel Analysis
    • 7.1. Global nanoemulsion market: Distribution Channel overview
      • 7.1.1. Global nanoemulsion market revenue share, by distribution channel, 2018 and 2025
    • 7.2. Retail Pharmacy
      • 7.2.1. Global nanoemulsion market for retail pharmacy, 2017-2025 (USD Million)
    • 7.3. Hospital Pharmacy
      • 7.3.1. Global nanoemulsion market for hospital pharmacy, 2017-2025 (USD Million)
    • 7.4. Online Pharmacy
      • 7.4.1. Global nanoemulsion market for online pharmacy, 2017-2025 (USD Million)
  •  
  • Chapter 8. Global Nanoemulsion Market - Regional Analysis
    • 8.1. Global nanoemulsion market: Regional overview
      • 8.1.1. Global nanoemulsion market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
      • 8.2.2. North America nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
      • 8.2.3. North America nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.2.4.2. The U.S. nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.2.4.3. The U.S. nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.2.5.2. Canada nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.2.5.3. Canada nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
      • 8.3.2. Europe nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
      • 8.3.3. Europe nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.4.2. Germany nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.4.3. Germany nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.5. France
        • 8.3.5.1. France nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.5.2. France nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.5.3. France nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.6. UK
        • 8.3.6.1. UK nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.6.2. UK nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.6.3. UK nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.7.2. Italy nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.7.3. Italy nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.8.2. Spain nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.8.3. Spain nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.3.9.2. Rest of Europe nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.3.9.3. Rest of Europe nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
      • 8.4.2. Asia Pacific nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
      • 8.4.3. Asia Pacific nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.4.4.2. China nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.4.4.3. China nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.4.5.2. Japan nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.4.5.3. Japan nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.4.6.2. India nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.4.6.3. India nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.4.7.2. Southeast Asia nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.4.7.3. Southeast Asia nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
      • 8.5.2. Latin America nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
      • 8.5.3. Latin America nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.5.4.2. Brazil nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.5.4.3. Brazil nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
      • 8.6.2. The Middle East and Africa nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
      • 8.6.3. The Middle East and Africa nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.6.4.2. GCC Countries nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.6.4.3. GCC Countries nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.6.5. South Africa
        • 8.6.5.1. South Africa nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.6.5.2. South Africa nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.6.5.3. South Africa nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
      • 8.6.6. Rest of MEA
        • 8.6.6.1. Rest of MEA nanoemulsion market revenue, by drug class, 2017-2025 (USD Million)
        • 8.6.6.2. Rest of MEA nanoemulsion market revenue, by route of administration, 2017-2025 (USD Million)
        • 8.6.6.3. Rest of MEA nanoemulsion market revenue, by distribution channel, 2017-2025 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Mitsubishi Tanabe Pharma
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. AbbVie
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Allergan
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Fresenius Kabi
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. AstraZeneca
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. GlaxoSmithKline
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Kaken Pharmaceutical
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Sanofi
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Novartis
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. B. Braun Melsungen
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Methodology

Free Analysis

Nanoemulsion is the novel drug delivery system or targeted drug delivery system that consists of water and emulsified oil with an average droplet diameter ranging from 50 to 1000 nm. Water in oil and oil in water are the two types of emulsion phases, which depends on the core particle that is either water or oil. The nanoemulsion-based drugs provide increased bioavailability of the drug molecule by providing target specific drug delivery. The nanoemulsion technique is used for drugs or active pharmaceutical ingredients whose solubility is low to poor. The nanoemulsions have good capacity to dissolve low soluble drugs and protect the drugs from enzymatic degradation or hydrolysis. The major advantages of nanoemulsions as drug delivery carriers include improved drug loading, enhanced bioavailability and drug solubility, controlled drug release, and reduced patient variability and protection from enzymatic degradation. This is the major factor driving the global nanoemulsion market. Nanoemulsions have extensive applications in different fields like food technology, pharmaceutics, and cosmetics. The pharmaceutical application of nanoemulsions includes the various routes of administration, which is another factor supporting this global market’s growth. Recently, nanoemulsions are commonly used for delivery of DNA-encoded drug, vaccine, antibiotics, and topical preparations, which, in turn, will generate new growth opportunities for the nanoemulsion market globally in the future.

Based on drug class, the global nanoemulsion market includes anesthetics, steroids, NSAIDs, immunosuppressant, antimicrobials, antiretroviral, vasodilators, and others. NSAIDs are expected to register notable growth in the future, owing to the increasing NSAIDs usage for various applications. By route of administration, the global nanoemulsion market includes topical, parenteral, oral, and nasal. By distribution channel, the global nanoemulsion market includes retail pharmacy, hospital pharmacy, and online pharmacy. Retail pharmacies are estimated to dominate the global nanoemulsion market over the estimated time period.

Global Nanoemulsion Market

By region, North America is expected to dominate the global nanoemulsion market over the forecast time period. Well-established biotechnology and pharmaceutical and industries, rising number of research activities for new drug development, increasing prevalence of chronic disorders, growing technological advancements in drug delivery techniques across the region are expected to boost the North American nanoemulsion market in the years ahead. Asia Pacific nanoemulsion market is projected to grow at the highest rate during the projected time period, owing to the increasing income of people and altering regional demographics.

Some major players operating in the global nanoemulsion market are Mitsubishi Tanabe Pharma, AbbVie, Allergan, Fresenius Kabi, AstraZeneca, GlaxoSmithKline, Kaken Pharmaceutical, Sanofi, Novartis, and B. Braun Melsungen.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social